Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anixa Biosciences | ANIX | Jan 24, 2025 | 2.82 | -3.42 |
Annaly Capital Management | NLY | Jan 24, 2025 | 19.48 | +0.67 |
Annaly Capital Management F Pref | NLY-F | Jan 24, 2025 | 25.72 | +0.16 |
Annaly Capital Management G Pref | NLY-G | Jan 24, 2025 | 25.44 | +0.24 |
Annaly Capital Management I Pref | NLY-I | Jan 24, 2025 | 25.78 | +0.31 |
Annexon | ANNX | Jan 24, 2025 | 4.13 | -2.59 |
Annovis Bio | ANVS | Jan 24, 2025 | 4.92 | -3.72 |
ANSYS | ANSS | Jan 24, 2025 | 357.37 | -0.83 |
Antelope Enterprise | AEHL | Jan 24, 2025 | 0.16 | +0.13 |
Anteris Technologies Global | AVR | Jan 24, 2025 | 5.99 | 0.00 |
Anterix | ATEX | Jan 24, 2025 | 29.81 | +0.98 |
Antero Midstream | AM | Jan 24, 2025 | 16.39 | -1.09 |
Antero Resources | AR | Jan 24, 2025 | 40.15 | -0.99 |
Anywhere Real Estate | HOUS | Jan 24, 2025 | 3.79 | -1.30 |
Aon | AON | Jan 24, 2025 | 369.16 | +1.23 |
APA | APA | Jan 24, 2025 | 23.32 | -0.81 |
Apartment Investment and Management | AIV | Jan 24, 2025 | 8.93 | 0.00 |
Apellis Pharmaceuticals | APLS | Jan 24, 2025 | 30.00 | -2.47 |
APi Group | APG | Jan 24, 2025 | 38.18 | +0.10 |
Apogee Enterprises | APOG | Jan 24, 2025 | 55.04 | -1.24 |
Apogee Therapeutics | APGE | Jan 24, 2025 | 40.28 | +0.17 |
Apollo Commercial Real Estate Finance | ARI | Jan 24, 2025 | 8.93 | +0.56 |
Apollo Global Management | APO | Jan 24, 2025 | 172.06 | +1.36 |
Apollomics | APLM | Jan 24, 2025 | 9.32 | -1.95 |
AppFolio A | APPF | Jan 24, 2025 | 250.03 | -4.07 |
Appian A | APPN | Jan 24, 2025 | 33.52 | -0.50 |
Apple | AAPL | Jan 24, 2025 | 222.78 | -0.39 |
Apple Hospitality REIT | APLE | Jan 24, 2025 | 15.16 | -0.66 |
Applied Digital | APLD | Jan 24, 2025 | 8.96 | -3.34 |
Applied DNA Sciences | APDN | Jan 24, 2025 | 0.18 | -7.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.